Phase I Trial of a Peptide-Based Vaccine to Prevent Group A Streptococcal Infection
Michael F. Good(Griffith University), Michael Houghton(University of Alberta), Ailin Lepletier(Griffith University), Simone Reynolds(Griffith University), Chris Davis(Fred Hutch Cancer Center), Ainslie Calcutt(Griffith University), Catherine Burton, Maryna Yaskina(University of Alberta), Christie Short(Griffith University), Michael Hawkes(University of British Columbia), Joshua Osowicki(Royal Children's Hospital), Manisha Pandey(Griffith University), Scott Jamieson(University of Alberta), Vanessa Meier‐Stephenson(University of Alberta), Andrew C. Steer(The University of Melbourne), Eloise C. Keeffe(Griffith University), Victoria Ozberk(Griffith University), D. Lorne Tyrrell(University of Alberta), Conar O’Neil(University of Alberta), Alena Tse‐Chang(University of Alberta), Ijeoma Ogbuehi(University of Alberta), Kelly Kim(University of Alberta), William Stokes(Emory University), Greg Tyrrell(St George's, University of London), B. Tyrrell(University of Alberta)
Cited by 0
Related Papers
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
|New England Journal of Medicine|1989|1.7k
A proposed system for the nomenclature of hepatitis C viral genotypes
|Hepatology|1994|1k
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses
|Clinical Infectious Diseases|2017|453
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
|Cancer Discovery|2019|272